Modalidades de fototerapia para el tratamiento de la dermatitis atópica: revisión sistemática de la literatura

Pérez‐Ferriols, A.; Aranegui, Beatriz; Pujol-Montcusí, Josep; Martín-Gorgojo, Alejandro; Campos‐Domínguez, Minia; Feltes, Rosa; Gilaberte, Yolanda; Echeverría-García, B.; Alvarez-Pérez, A.; García‐Doval, I.

doi:10.1016/j.ad.2014.12.017

Cited by 20 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, some therapies involve the functioning of stationary dermatological units, such as phototherapy [20]. Most of the therapeutic options used to treat more severe forms of AD undoubtedly have an effect on the patients' immune systems.…”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients

Sieniawska

Lesiak

Ciążyński

et al. 2022

IJERPH

View full text Add to dashboard Cite

Atopic dermatitis (AD) can have a significantly negative impact on quality of life (QoL). The impact of coronavirus disease 2019 (COVID-19) on the AD population is not yet well established. The study comprised 195 patients with diagnosed AD who were asked about their cognitive and preventive behaviors regarding COVID-19 and the accessibility of medical support, including online consultations. Moreover, the patients responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale (HADS). Most of the patients were worried about being infected with COVID-19. Most of the patients believed that people suffering from skin disease were more prone to be infected with COVID-19 compared with the general population. Most the patients negatively assessed the availability of dermatological treatment during the pandemic. Furthermore, 66.1% of the patients declared using telemedicine. Nearly 50% of patients were discontented with telemedicine, and 1/3 of the patients did not mind the use of telemedicine. AD during the COVID-19 pandemic was associated with a lower overall health rating and life satisfaction and impaired QoL related to mental health in a Polish population. These results provide original information that can be applied in dermatologic patient screenings to evaluate the state of depression and anxiety during the epidemic period.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients

Sieniawska

Lesiak

Ciążyński

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…However, UVA1 is preferable for controlling acute flare of atopic dermatitis while NBUVB is most effective in managing chronic disease. Another systematic review by Pérez-Ferriols et al 16 , described two studies according to which NBUVB was found to be superior than medium dose UV-A1, with a better reduction of pruritus compared to medium dose UVA1. Moreover, UVA1 has potential association with photo-carcinogenesis like melanoma and Merkel cell carcinoma.…”

Section: Discussionmentioning

confidence: 99%

Narrowband UV-B phototherapy in childhood atopic dermatitis: efficacy and safety

Dayal

Pathak²,

Sahu

et al. 2017

An. Bras. Dermatol.

View full text Add to dashboard Cite

BackgroundNarrow-band UVB is the most innovative steroid sparing treatment in atopic dermatitis. There are studies showing efficacy of Narrow-band UVB in childhood atopic dermatitis, but there is lack of clinical trials in the literature determining the length of remission. Therefore, we sought to highlight its efficacy, safety and its post-treatment efficacy in childhood atopic dermatitis.ObjectiveTo assess the clinical efficacy, safety of Narrow-band UVB in the treatment of paediatric atopic dermatitis and length of remission during 2 years of post-treatment follow-up.MethodsThirty children (4-14 years) having moderate to severe AD (SCORAD index > 25) were enrolled for 12 weeks. Narrow-band UVB phototherapy was administered twice a week on non-consecutive days for three months. SCORAD index was calculated by the same dermatologist at baseline, 6th, 12th, 18th and 24th treatment session. Secondary outcomes were measured using visual analog scale for pruritus and sleep loss. Patients were also followed-up for 2 years to know the length of remission after end of therapy.ResultsThere was a significant reduction in SCORAD index at 6th, 12th, 18th and 24th treatment session in comparison to baseline. This improvement in SCORAD was also maintained during the 2 years of post-treatment follow-up period. Consequently, pruritus and sleep loss improved significantly from baseline to end of therapy and even during the 1st and 2nd year of follow-up.Study limitationOpen-label trial without control group.ConclusionsNarrow-band UVB is an efficacious and safe modality of treatment in childhood atopic dermatitis with good therapeutic index and minimal side effects.

show abstract

“…Phototherapy (specifically broadband UVB) in atopic dermatitis has been used since 1970 and its effectiveness is clinically proven [1]. The mechanism of skin lesions development in atopic dermatitis is connected with activation of T-cell infiltration into the skin, which leads to increasing proliferation of keratinocytes and as a result thickening of the skin.…”

Section: Mechanism Of Actionmentioning

confidence: 99%

“…The effectiveness and relapse time do not differ strongly between these two options of therapy. Therefore the UVA-A1 radiation should be the preferable one [1]. UVA-A1 in low doses is practically ineffective, thereby it is not considered to be a therapeutic agent [28].…”

Section: Uva1mentioning

confidence: 99%

Phototherapy in Atopic Dermatitis

Lesiak¹,

Ciążyńska²

2021

Atopic Dermatitis - Essential Issues

View full text Add to dashboard Cite

Atopic dermatitis (AD) is an inflammatory, recurrent and chronic disease that occurs in 2–10% of the population. Therapy of AD could be divided into topical (corticosteroids, calcineurin inhibitors) and systemic (cyclosporine, methotrexate, azathioprine or biological treatment). Phototherapy is taken into consideration as a second-line treatment, when topical therapy is unsuccessful. We distinguish many types of phototherapy, e.g. narrowband UVB (311–313 nm), UVA-1 therapy (340–400 nm), UVA/B combination, UVA therapy plus 8-methoxypsoralens (PUVA), 308 nm excimer laser (EL) and blue light. Phototherapy is effective in many cases, whether in adults or in children. It should be remembered that during therapy possible side effects may occur. Among them the risk of carcinogenesis is the most severe.

show abstract

Modalidades de fototerapia para el tratamiento de la dermatitis atópica: revisión sistemática de la literatura

Cited by 20 publications

References 28 publications

Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients

Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients

Narrowband UV-B phototherapy in childhood atopic dermatitis: efficacy and safety

Phototherapy in Atopic Dermatitis

Contact Info

Product

Resources

About